Measuring the biological effect of presurgical metformin treatment in endometrial cancer

BACKGROUND: Preclinical studies in endometrial cancer (EC) show that metformin reduces cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term presurgical metformin reduces cellular proliferation in atypical endometrial hyperplasia (AEH) and endometrioid EC, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivalingam, V N, Kitson, S, McVey, R, Roberts, C, Pemberton, P, Gilmour, K, Ali, S, Renehan, A G, Kitchener, H C, Crosbie, E J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742583/
https://www.ncbi.nlm.nih.gov/pubmed/26794276
http://dx.doi.org/10.1038/bjc.2015.453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742583/
https://www.ncbi.nlm.nih.gov/pubmed/26794276
http://dx.doi.org/10.1038/bjc.2015.453

Ejemplares similares